Determination of optimal loading and maintenance doses for continuous infusion of vancomycin in critically ill patients: Population pharmacokinetic modelling and simulations for improved dosing schemes

被引:22
|
作者
Vu, Dinh H. [1 ]
Nguyen, Duy A. [1 ]
Delattre, Isabelle K. [2 ]
Ho, Trong T. [1 ]
Do, Hong G. [3 ]
Pham, Hong N. [4 ]
Dao, Xuan C. [5 ]
Tran, Nhan T. [3 ]
Nguyen, Gia B. [5 ]
Van Bambeke, Francoise [2 ]
Tulkens, Paul M. [2 ]
Nguyen, Hoang A. [1 ]
机构
[1] Hanoi Univ Pharm, Natl Drug Informat & Adverse Drug React Monitorin, 13-15 Le Thanh Tong, Hanoi, Vietnam
[2] Catholic Univ Louvain, Louvain Drug Res Inst, Brussels, Belgium
[3] Bach Mai Hosp, Dept Pharm, Hanoi, Vietnam
[4] Bach Mai Hosp, Dept Microbiol, Hanoi, Vietnam
[5] Bach Mai Hosp, Intens Care Unit, Hanoi, Vietnam
关键词
Vancomycin; Continuous infusion; Loading dose; Maintenance dose; Critically ill; AUGMENTED RENAL CLEARANCE; INTENSIVE-CARE-UNIT; STAPHYLOCOCCUS-AUREUS; INTERMITTENT INFUSION; PHARMACODYNAMICS; INFECTIONS; SIZE;
D O I
10.1016/j.ijantimicag.2019.09.018
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: Despite extensive clinical use, limited data are available on optimal loading and maintenance doses of vancomycin in critically ill patients. This study aimed to develop a rational approach for optimised dosage of vancomycin given in a continuous infusion in critically ill patients. Methods: Vancomycin pharmacokinetic (PK) data (total serum concentrations) were obtained from 55 intensive care unit (ICU) patients (Bach Mai Hospital, Hanoi, Vietnam) receiving a 20 mg/kg loading dose followed by continuous infusion stratified by creatinine clearance (CLCr). Population PK modelling and Monte Carlo simulations were performed using a nonlinear mixed-effects modelling (NONMEM) program for a target of 20-30 mg/L to optimise efficacy and minimise nephrotoxicity. Results: A two-compartment model with first-order elimination best fitted the PK data with central and peripheral volumes of distribution of 1.01 and 2.39 L/kg, respectively (allometric scaling to a 70 kg standard subject). The population total clearance of 3.63 L/h was only explained by renal function in the covariate and final model. The simulations showed that a 25-mg/kg loading dose infused over 90 minutes was optimal to reach the target range. The optimal maintenance dose for low renal function (CLCr < 45 mL/min) was 1000-1500 mg/day. For augmented renal clearance (CLCr > 130 mL/min) the dose should be up to 3500 mg/day or even 4500 mg/day to achieve adequate exposure. These simulated maintenance doses were larger than previously proposed for non-ICU patients. Conclusion: Large loading and maintenance doses of vancomycin are generally needed in critically ill patients. Because of high interindividual variability in vancomycin PK, drug monitoring may still be necessary. (C) 2019 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:702 / 708
页数:7
相关论文
共 39 条
  • [21] Determination of vancomycin exposure target and individualized dosing recommendations for critically ill patients undergoing continuous renal replacement therapy
    Wang, Chuhui
    Chen, Jiaojiao
    Yang, Bo
    Li, Sihan
    Zhang, Yiran
    Chen, Lei
    Wang, Taotao
    Dong, Yalin
    PHARMACOTHERAPY, 2023, 43 (03): : 180 - 188
  • [22] A Loading Micafungin Dose in Critically Ill Patients Undergoing Continuous Venovenous Hemofiltration or Continuous Venovenous Hemodiafiltration: A Population Pharmacokinetic Analysis
    Garbez, Nicolas
    Mbatchi, Litaty C.
    Maseda, Emilio
    Luque, Sonia
    Grau, Santiago
    Wallis, Steven C.
    Muller, Laurent
    Lipman, Jeffrey
    Roberts, Jason A.
    Lefrant, Jean-Yves
    Roger, Claire
    THERAPEUTIC DRUG MONITORING, 2021, 43 (06) : 747 - 755
  • [23] Population pharmacokinetics and individualized dosing of vancomycin for critically ill patients receiving continuous renal replacement therapy: the role of residual diuresis
    Yu, Zhenwei
    Liu, Jieqiong
    Yu, Haitao
    Zhou, Ling
    Zhu, Jianping
    Liang, Gang
    Yang, Yi
    Zheng, Ying
    Han, Yun
    Xu, Junjun
    Han, Gang
    Yu, Lingyan
    Zhao, Yuhua
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [24] Letter to the Editor : "An optimal extended-infusion dosing of cefepime and ceftazidime in critically ill patients with continuous renal replacement therapy"
    Honore, PatrickM.
    Redant, Sebastien
    Djimafo, Pharan
    Preseau, Thierry
    Cismas, Bogdan Vasile
    Kaefer, Keitiane
    Gutierrez, Leonel Barreto
    Anane, Sami
    Gallerani, Andrea
    Attou, Rachid
    JOURNAL OF CRITICAL CARE, 2022, 70
  • [25] Author response: "An optimal extended-infusion dosing of cefepime and ceftazidime in critically ill patients with continuous renal replacement therapy"
    Sember, Addison M.
    LoFaso, Megan E.
    Lewis, Susan J.
    JOURNAL OF CRITICAL CARE, 2022, 70
  • [26] Population Pharmacokinetic Meta-Analysis and Dosing Recommendation for Meropenem in Critically Ill Patients Receiving Continuous Renal Replacement Therapy
    Peng, Yaru
    Cheng, Zeneng
    Xie, Feifan
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (09)
  • [27] Population pharmacokinetics and evaluation of the predictive performance of pharmacokinetic models in critically ill patients receiving continuous infusion meropenem: a comparison of eight pharmacokinetic models
    Dhaese, Sofie A. M.
    Farkas, Andras
    Colin, Pieter
    Lipman, Jeffrey
    Stove, Veronique
    Verstraete, Alain G.
    Roberts, Jason A.
    De Waele, Jan J.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2019, 74 (02) : 432 - 441
  • [28] Optimal Teicoplanin Dosage Regimens in Critically Ill Patients: Population Pharmacokinetics and Dosing Simulations Based on Renal Function and Infection Type
    Wang, Yifan
    Yao, Fen
    Chen, Shenglong
    Ouyang, Xin
    Lan, Jinhua
    Wu, Zheng
    Wang, Yirong
    Chen, Jingchun
    Wang, Xipei
    Chen, Chunbo
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2023, 17 : 2259 - 2271
  • [29] A Population Pharmacokinetic Model-Guided Evaluation of Ceftolozane-Tazobactam Dosing in Critically Ill Patients Undergoing Continuous Venovenous Hemodiafiltration
    Sime, Fekade B.
    Lassig-Smith, Melissa
    Starr, Therese
    Stuart, Janine
    Pandey, Saurabh
    Parker, Suzanne L.
    Wallis, Steven C.
    Lipman, Jeffrey
    Roberts, Jason A.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (01)
  • [30] Optimal vancomycin dosing regimens for critically ill patients with acute kidney injury during continuous renal replacement therapy: A Monte Carlo simulation study
    Charoensareerat, Taniya
    Chaijamorn, Weerachai
    Boonpeng, Apinya
    Srisawat, Nattachai
    Pummangura, Chalermsri
    Pattharachayakul, Sutthiporn
    JOURNAL OF CRITICAL CARE, 2019, 54 : 77 - 82